» Articles » PMID: 38409439

Interferons Are Key Cytokines Acting on Pancreatic Islets in Type 1 Diabetes

Abstract

Aims/hypothesis: The proinflammatory cytokines IFN-α, IFN-γ, IL-1β and TNF-α may contribute to innate and adaptive immune responses during insulitis in type 1 diabetes and therefore represent attractive therapeutic targets to protect beta cells. However, the specific role of each of these cytokines individually on pancreatic beta cells remains unknown.

Methods: We used deep RNA-seq analysis, followed by extensive confirmation experiments based on reverse transcription-quantitative PCR (RT-qPCR), western blot, histology and use of siRNAs, to characterise the response of human pancreatic beta cells to each cytokine individually and compared the signatures obtained with those present in islets of individuals affected by type 1 diabetes.

Results: IFN-α and IFN-γ had a greater impact on the beta cell transcriptome when compared with IL-1β and TNF-α. The IFN-induced gene signatures have a strong correlation with those observed in beta cells from individuals with type 1 diabetes, and the level of expression of specific IFN-stimulated genes is positively correlated with proteins present in islets of these individuals, regulating beta cell responses to 'danger signals' such as viral infections. Zinc finger NFX1-type containing 1 (ZNFX1), a double-stranded RNA sensor, was identified as highly induced by IFNs and shown to play a key role in the antiviral response in beta cells.

Conclusions/interpretation: These data suggest that IFN-α and IFN-γ are key cytokines at the islet level in human type 1 diabetes, contributing to the triggering and amplification of autoimmunity.

Citing Articles

Interferon-α promotes HLA-B-restricted presentation of conventional and alternative antigens in human pancreatic β-cells.

Carre A, Samassa F, Zhou Z, Perez-Hernandez J, Lekka C, Manganaro A Nat Commun. 2025; 16(1):765.

PMID: 39824805 PMC: 11748642. DOI: 10.1038/s41467-025-55908-9.


LRH-1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype.

Cobo-Vuilleumier N, Rodriguez-Fernandez S, Lopez-Noriega L, Lorenzo P, Franco J, Lachaud C Clin Transl Med. 2024; 14(12):e70134.

PMID: 39702941 PMC: 11659195. DOI: 10.1002/ctm2.70134.


Reduction of Chemokine CXCL9 Expression by Omega-3 Fatty Acids via ADP-Ribosylhydrolase ARH3 in MIN6 Insulin-Producing Cells.

You Y, Sarkar S, Deiter C, Elliott E, Nicora C, Mirmira R Proteomics. 2024; 25(3):e202400053.

PMID: 39648458 PMC: 11794668. DOI: 10.1002/pmic.202400053.


Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8 T cell activity and biomarker during the evolution of type 1 diabetes.

Rao C, Cater D, Roy S, Xu J, De Oliveira A, Evans-Molina C Diabetologia. 2024; 68(2):382-396.

PMID: 39508879 DOI: 10.1007/s00125-024-06313-2.


β-Cell gene expression stress signatures in types 1 and 2 diabetes.

Yi X, Eizirik D J Diabetes. 2024; 16(11):e70026.

PMID: 39505716 PMC: 11540585. DOI: 10.1111/1753-0407.70026.


References
1.
Eizirik D, Pasquali L, Cnop M . Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol. 2020; 16(7):349-362. DOI: 10.1038/s41574-020-0355-7. View

2.
Atkinson M, Eisenbarth G, Michels A . Type 1 diabetes. Lancet. 2013; 383(9911):69-82. PMC: 4380133. DOI: 10.1016/S0140-6736(13)60591-7. View

3.
Mathieu C, Martens P, Vangoitsenhoven R . One hundred years of insulin therapy. Nat Rev Endocrinol. 2021; 17(12):715-725. DOI: 10.1038/s41574-021-00542-w. View

4.
Ramos-Rodriguez M, Raurell-Vila H, Colli M, Alvelos M, Subirana-Granes M, Juan-Mateu J . The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes. Nat Genet. 2019; 51(11):1588-1595. PMC: 7040466. DOI: 10.1038/s41588-019-0524-6. View

5.
Calderon B, Suri A, Pan X, Mills J, Unanue E . IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes. J Immunol. 2008; 181(10):6964-74. PMC: 2653256. DOI: 10.4049/jimmunol.181.10.6964. View